Ticker Details
Harmony Biosciences Holdings, Inc.
IPO Date:	August 19, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.22B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.87 | 2.37%
Avg Daily Range (30 D):	$0.80 | 2.20%
Avg Daily Range (90 D):	$0.76 | 2.29%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	.64M
Avg Daily Volume (90 D):	.65M

Trade Size
Avg Trade Size (Sh.):	52
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	50

Institutional Trades
Total Institutional Trades:	2,323
Avg Institutional Trade:	$2.44M
Avg Institutional Trade (30 D):	$3.5M
Avg Institutional Trade (90 D):	$3.2M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.15M
Avg Closing Trade (30 D):	$5.39M
Avg Closing Trade (90 D):	$5.04M
Avg Closing Volume:	88.8K

News

May 19, 2026 @ 9:33 PM A beaten-down biotech just lost a meaningful backe... Source: Seena Hassouna

Apr 16, 2026 @ 5:21 PM 12 Small-Cap Stocks Primed for Breakouts as Earnin... Source: David Wagner

Feb 1, 2026 @ 3:19 AM Harmony Biosciences' CFO Sells All of Her Insider ... Source: Adé Hennis

Jan 27, 2026 @ 5:02 PM Harmony Biosciences' Sales and Profits Have Soared... Source: Dan Caplinger

Apr 8, 2025 @ 5:00 PM Developmental and Epileptic Encephalopathies Marke... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$3.14	$1.3	$.56
Diluted EPS	$3.1	$1.28	$.55
Revenue	$959.9M	$261.28M	$215.39M
Gross Profit	$723.99M	$198.08M	$170.88M
Net Income / Loss	$181.27M	$75.43M	$32.49M
Operating Income / Loss	$230.65M	$89.32M	$37.29M
Cost of Revenue	$235.91M	$63.2M	$44.51M
Net Cash Flow	$3.72M	$-39.63M	$-163.1M
PE Ratio